Navigation Links
EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007
Date:11/3/2007

TARRYTOWN, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it will host a conference call to discuss third quarter 2007 results and provide a business update on Wednesday, November 7, 2007 at 8:30 a.m. EST. EpiCept will release results for the three and nine months ended September 30, 2007 at 12:01 a.m. EST on Monday, November 5, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

To participate in the live call, please dial (888) 802-7346 from the U.S. or Canada or (973) 582-2785 from international locations (please reference access code 9431155). The conference call will also be broadcast live on the Internet and may be accessed at http://www.epicept.com. The webcast will be archived for 90 days.

A telephone replay of the call will be available for seven days by dialing (877) 519-4471 from the U.S. and Canada or (973) 341-3080 from international locations (please reference reservation number 9431155).

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. EpiCept has a staged portfolio of pharmaceutical product candidates with several pain therapies in late-stage clinical trials, and a lead oncology compound for AML with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound has been submitted in Europe. EpiCept is headquartered in Tarrytown, N.Y. Its research and development team in San Diego is pursuing a drug discovery program focused on novel approaches to apoptosis.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. EpiCept Accelerates Development of Phase I Clinical Study for Cancer
2. Third artificial heart patient introduced
3. Extra hormone found to cut appetite by a third
4. Third generation Small pox vaccine from Cell-culture
5. Surgery Offers Better Treatment For Third Degree Piles
6. One Third Of All Cancers Preventable!
7. Britain Announces Third Transfusion Related Mad Cow Case
8. Kleins Third Way Has Tough Opposition
9. Ignorance about AIDS rampart in Third of College Students: Chinese survey
10. Wake-up Call: Two-thirds of Briton Spend Many Sleeping Moments Awake!
11. Jalgaon: Third Phase Of Culling Operations Begin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...tate to take breast cancer drug, study finds , ...s about side effects are a major reason why only 6... cancer are willing to take the drug tamoxifen to ... effort to inform women about the risks and benefi...Michigan Comprehensive Cancer Center created a dec...
(Date:12/4/2009)...tor Showcasing Innovative Health Product in Scotts..., 2009 -- A valley inventor garnering national att...s lose weight, prevent disease, restore health, im...ng the product at Saturday’s Technology Fair...ekDesk has been featured on major television netw...
(Date:12/4/2009)...ec. 4 Today, seven of Florida,s to...roving the health of Florida,s uninsured and under...a,s 2009 Sapphire Award ceremony. ,, The Sapphi...cognizes and promotes organizations that have demo...es within their communities. ,, Honorees of The...
(Date:12/4/2009)...ire-USNewswire/ -- As Congress prepares to vote on...cil (FRC) today announced an eight week campaign t... each household on provisions of the Senate health...ning, higher taxes, and government-run health care...xpress opposition to the so-called health care ref...
(Date:12/4/2009)...wswire-FirstCall/ -- Movado Group Inc. (NYSE: MO...lanta, Georgia, shared in a tribute on December 3,...elanie Oudin for her stellar performance in the to...rterfinalist at the Open since 1999. ,, (Photo...Y21184 ) ,, At a celebratory reception held at ...
Breaking Medicine News(10 mins):Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2
...arch presented at Digestive Disease Week 2005, ant...l bleedings. Clinical depression, also known ...depressant drugs like selective serotonin reuptake...leeding and hemorrhage in gastro intestinal tracts...
...rom Wake Forest University Baptist Medical Center,...orks equally well for children with cancer, and th... The researchers had looked into the chemothe...ery limited dosage of chemotherapy and were monito...
...ering from Attention Deficit Hyperactivity Syndrom...n with the help of sensory interventions like appl...us exercise, etc. Attention Deficit Hyperacti...to be impulsive, inattentive and hyperactive. Rece...
...ave identified a virus that targets and kills a ty...omatitis virus (VSV) can successfully target and k...rms of brain tumors. Glioblastoma is a form of bra...viruses through a series of tests to find out the ...
...rom Netherlands have found out that certain ordina...l drugs can cause deaths from cardiac arrest. ...n Heart Journal, said that the non-cardiac drugs i...rolong the duration of electrical activity that co...
... report done by Swedish scientists its said that i...ge of prostate cancer than to wait and see if the ...tate cancer, also known as prostatectomy, is a com...watching and waiting the cancer in the prostate gl...
Other Medicine News:
(Date:12/3/2009)... , NEW YORK, Dec. 3 Guidepo... today announced the launch of their Sleep Apnea T...onitors and projects trends and market share in th...pnea Tracker captures actual patient usage for 87 ...ed States from 15 different equipment providers go...
(Date:12/3/2009)... , DOYLESTOWN, Pa., Dec. 3 /PRNewswire-F...uigley Corporation, (Nasdaq: QGLY ) www.quigleyc...ted its evaluation of its opportunities to develop...has concluded that it is in its best interests to ...ce, which may include but are not limited to its C...
(Date:12/3/2009)... , FORT WORTH, Texas, Dec. 3 /PRNewsw... Inc. (OTC Bulletin Board: WNDM), a rapidly growin...d today an agreement with the Health Industry Repr...clusive independent sales and marketing representa...; product within the U.S. ,, HIRA will marke...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3UPDATE 3A U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61768 1UPDATE 3A U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61768 2DONG Energy and Inbicon Inaugurate One of the Worlds Largest Demo Plants for 2nd Generation Biofuel 14927 1DONG Energy and Inbicon Inaugurate One of the Worlds Largest Demo Plants for 2nd Generation Biofuel 14927 2Heska Announces Launch of New Website 6422 1Heska Announces Launch of New Website 6422 2Heska Announces Launch of New Website 6422 3
...land and first center in the world to,focus exclus...BOSTON, Sept. 10 The U.S. National,Institutes of ...nique,collaboration of researchers, clinicians, pa...tical/biomedical companies to study the causes and...ular dystrophy (FSHD), a,muscle weakening and disa...
...RNewswire-FirstCall/ -- China Sky One,Medical, Inc...: CSY ), a,leading fully integrated pharmaceutica...People,s Republic of China ("PRC"), announced toda... are currently in clinical trials., Heilongjiang ...ly-owned,subsidiary of China Sky One Medical, rece...
Other Medicine Technology:NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute 2NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute 3NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute 4China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials 2China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials 3
Tumbling E Pad(100 sheets) BCE
...riced 2-channel data acquisition system suitable f...n and animal physiology, pharmacology, neurophysio...l engineering. The PowerLab 2/25 supports all ADIn... Pod ports are featured allowing direct connection...
... data acquisition system suitable for a wide range...al physiology, pharmacology, neurophysiology, biol...ring. The unit is capable of recording from very s... second continuously to disk), and is compatible w...
Worth 4 Dot Test
Medicine Products: